180 related articles for article (PubMed ID: 18425371)
61. Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells.
Li R; Hehlman R; Sachs R; Duesberg P
Cancer Genet Cytogenet; 2005 Nov; 163(1):44-56. PubMed ID: 16271955
[TBL] [Abstract][Full Text] [Related]
62. [Mifepristone modulates glucosylceramide synthase expression and reverse multidrug resistance in ovarian cancer cells].
Liu Y; Wang LL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1727-30. PubMed ID: 18819906
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin.
Limtrakul P; Khantamat O; Pintha K
J Chemother; 2005 Feb; 17(1):86-95. PubMed ID: 15828450
[TBL] [Abstract][Full Text] [Related]
64. [Mechanisms of drug resistance in human ovarian carcinoma studied by comparative genomic hybridization].
Ying HC; Zhang SL; Jiang T; Ouyang L; Lü J
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1009-12. PubMed ID: 17672960
[TBL] [Abstract][Full Text] [Related]
65. [The karyotypic variability of Chinese hamster CHLV-79 RJK cells characterized by multiple drug resistance resulting from the amplification of the mdr gene family].
Grinchuk TM; Lipskaia LA; Artsybasheva IV; Sorokina EA; Pan'shina IuT; Ignatova TN
Tsitologiia; 1996; 38(2):161-72. PubMed ID: 8754132
[TBL] [Abstract][Full Text] [Related]
66. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M
Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
[TBL] [Abstract][Full Text] [Related]
67. Amplicon profiling reveals cytoplasmic overexpression of MUC1 protein as an indicator of resistance to platinum-based chemotherapy in patients with ovarian cancer.
Takano M; Fujii K; Kita T; Kikuchi Y; Uchida K
Oncol Rep; 2004 Dec; 12(6):1177-82. PubMed ID: 15547734
[TBL] [Abstract][Full Text] [Related]
68. Torilin, a sesquiterpene from Torilis japonica, reverses multidrug-resistance in cancer cells.
Kim SE; Kim YH; Kim YC; Lee JJ
Planta Med; 1998 May; 64(4):332-4. PubMed ID: 9619115
[TBL] [Abstract][Full Text] [Related]
69. Integrated genome-wide gene expression map and high-resolution analysis of aberrant chromosomal regions in squamous cell lung cancer.
Zhang XY; Hu Y; Cui YP; Miao XP; Tian F; Xia YJ; Wu YQ; Liu X
FEBS Lett; 2006 May; 580(11):2774-8. PubMed ID: 16674950
[TBL] [Abstract][Full Text] [Related]
70. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
[TBL] [Abstract][Full Text] [Related]
71. Characterization and genetic analysis in the newly established human bile duct cancer cell lines.
Ghosh M; Koike N; Tsunoda S; Hirano T; Kaul S; Kashiwagi H; Kawamoto T; Ohkohchi N; Saijo K; Ohno T; Miwa M; Todoroki T
Int J Oncol; 2005 Feb; 26(2):449-56. PubMed ID: 15645130
[TBL] [Abstract][Full Text] [Related]
72. Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.
van Dekken H; Tilanus HW; Hop WC; Dinjens WN; Wink JC; Vissers KJ; van Marion R
Cancer Genet Cytogenet; 2009 Feb; 189(1):37-42. PubMed ID: 19167610
[TBL] [Abstract][Full Text] [Related]
73. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
74. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma.
van den Broek GB; Wreesmann VB; van den Brekel MW; Rasch CR; Balm AJ; Rao PH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4386-91. PubMed ID: 17671120
[TBL] [Abstract][Full Text] [Related]
75. Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization.
Shimizu H; Fukuda T; Ghazizadeh M; Nagashima M; Kawanami O; Suzuki T
Jpn J Cancer Res; 2002 Aug; 93(8):902-10. PubMed ID: 12716468
[TBL] [Abstract][Full Text] [Related]
76. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
Oudejans JJ; van Wieringen WN; Smeets SJ; Tijssen M; Vosse SJ; Meijer CJ; Meijer GA; van de Wiel MA; Ylstra B
Genes Chromosomes Cancer; 2009 Mar; 48(3):250-60. PubMed ID: 19051311
[TBL] [Abstract][Full Text] [Related]
77. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
Cappelletti V; Gariboldi M; De Cecco L; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
Endocr Relat Cancer; 2008 Jun; 15(2):439-49. PubMed ID: 18508997
[TBL] [Abstract][Full Text] [Related]
78. Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.
Nakagawa M; Akiyama S; Yamaguchi T; Shiraishi N; Ogata J; Kuwano M
Cancer Res; 1986 Sep; 46(9):4453-7. PubMed ID: 3731102
[TBL] [Abstract][Full Text] [Related]
79. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).
Chapman EJ; Williams SV; Platt FM; Hurst CD; Chambers P; Roberts P; Knowles MA
Genes Chromosomes Cancer; 2009 Aug; 48(8):694-710. PubMed ID: 19405089
[TBL] [Abstract][Full Text] [Related]
80. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
